Wordt geladen...
Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study
BACKGROUND: Efficacy of stereotactic body radiotherapy (SBRT) in stage I non–small-cell lung cancer (NSCLC) has almost been established. In Japan, the protocol of 48 Gy in 4 fractions over 4 days has been most often employed, but higher doses may be necessary to control large tumors. Previously, we...
Bewaard in:
| Gepubliceerd in: | Radiat Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5594596/ https://ncbi.nlm.nih.gov/pubmed/28893300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0888-7 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|